Global Molecular Diagnostics Market Forecast to Reach US$17.96 Billion in 2024, Growing at a CAGR of 6.16% from 2020 to 2024

NEXT STORY
Corvus Pharmaceuticals Provides Update on Clinical Trial of CPI-006 for Patients with COVID-19
PREV STORY
Genmab Announces that Janssen has Submitted a Supplemental Biologics License Application to U.S. FDA for use of DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj) in Patients with Light-chain (AL) Amyloidosis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

American Health Council Honors Cassie Banks, BSN, MS-FNP, DNP as “Best in Nursing”

NEW YORK, Nov. 20, 2017 (GLOBE NEWSWIRE) -- The American Health Council honors Cassie ...

author_avatar
NASDAQ Market News

Hemispherx to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

ORLANDO, Fla., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) ...

author_avatar
NASDAQ Market News

OraSure Technologies, Inc. Announces Two Acquisitions and Reaffirms Fourth Quarter 2018 Guidance

CoreBiome leverages OraSure’s leadership position in microbiome sample collection with end-to-end laboratory services for ...

author_avatar
NASDAQ Market News